Joanna Tierney, MD
Hospitalist · Riverton, UTNPI 1801996384
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Among hospitalist clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$58
- Sumitomo Pharma America, Inc.$40
- Lilly USA, LLC$33
- Exact Sciences$30
- AbbVie$30
- Inspire Medical Systems, Inc.$23
- plus $202 from 12 others
What the payments were for
- Food & beverage$416100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 3 | $58 |
| Sumitomo Pharma America, Inc. | 3 | $40 |
| Lilly USA, LLC | 2 | $33 |
| Exact Sciences | 2 | $30 |
| AbbVie | 1 | $30 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| GSK | 1 | $18 |
| Bayer | 1 | $18 |
| Amgen | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Pfizer | 1 | $16 |
| Merck | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Lucid Diagnostics Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Novo Nordisk | 1 | $14 |
How this compares
$416 in reported general payments places this provider in the 90th percentile of 203 hospitalist providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 100 | $115,489 |
| OzempicSemaglutide | 30 | $37,246 |
| JardianceEmpagliflozin | 32 | $28,609 |
| MyrbetriqMirabegron | 33 | $28,491 |
| TrulicityDulaglutide | 22 | $25,810 |
| FarxigaDapagliflozin Propanediol | 22 | $22,598 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 45 | $8,796 |
| LantusInsulin Glargine,hum.Rec.Anlog | 33 | $5,459 |
| Humalog Kwikpen U-100Insulin Lispro | 12 | $4,699 |
| DuleraMometasone/Formoterol | 12 | $4,185 |
| Omeprazole | 194 | $4,125 |
| Gabapentin | 159 | $2,969 |
| Atorvastatin Calcium | 377 | $2,779 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 103 | $2,754 |
| Levothyroxine Sodium | 330 | $2,687 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $16 | $115,489100 claims |
| Novo NordiskOzempic | $14 | $37,24630 claims |
| Astellas Pharma US IncMyrbetriq | $58 | $28,49133 claims |
| Lilly USA, LLCTrulicity | $33 | $25,81022 claims |
| Sanofi-aventis U.S. LLCLantus | $15 | $5,45933 claims |
| MerckDulera | $15 | $4,18512 claims |
| AbbVieSynthroid | $30 | $1,91435 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 203 hospitalist providers in Utah.
Other hospitalist in Riverton
- David GryglaSt George$400K
- Manuel JimenezMurray$16K
- Mark KellySalt Lake City$7K
- Margi BhattSalt Lake City$4K
- Beth HanlonSalt Lake City$3K
- Victoria WilkinsSalt Lake City$2K
- Valerie VaughnSalt Lake City$2K
- Smitha SadiqOgden$1K
- Michelle HofmannSalt Lake City$955
- Matthew RondinaSlc$900
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.